series-c-plus
Stage
1
Investors
About
Soley Therapeutics uses artificial intelligence combined with proprietary cell imaging and automation to analyze whole-cell responses to discover and develop first-in-class medicines for complex diseases including oncology and chronic conditions.
Explore Soley Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.